Statistical models of acute mountain sickness

被引:12
作者
Vann, RD
Pollock, NW
Pieper, CF
Murdoch, DR
Muza, SR
Natoli, MJ
Wang, LY
机构
[1] Duke Univ, Med Ctr, Dept Anesthesiol, Ctr Hyperbar Med & Evolut Physiol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Ctr Aging, Dept Biostat & Bioinformat, Durham, NC 27710 USA
[3] Univ Otago, Dept Pathol, Christchurch Sch Med & Hlth Sci, Christchurch, New Zealand
[4] USA, Res Inst Environm Med, Thermal & Mt Med Div, Natick, MA USA
[5] Duke Univ, Med Ctr, Sch Med, Durham, NC 27710 USA
关键词
altitude; probability; acclimatization; acetazolamide; Lake Louise;
D O I
10.1089/ham.2005.6.32
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Acute mountain sickness (AMS) is caused by exposure to altitudes exceeding 2500 m and often resolves by acclimatization without further ascent. Statistical models of AMS score and the probability of an AMS diagnosis were developed to allow the combination of dissimilar exposures for simultaneous analysis. The study population was 302 trekkers from a previous investigation who provided self-reported symptoms upon arrival at 3840 m during hikes through altitudes of 1500 to 6200 m. AMS score (Hackett scale) was estimated by linear regression and the probability of an AMS diagnosis (Lake Louise criteria) by logistic regression. AMS score or probability was significantly associated with exposure day and altitude. Increased altitude over the prior 3 days resulted in higher estimated AMS score or probability and decreased altitude in lower score or probability. The odds ratio (OR) of AMS was 3.6 if not on acetazolamide. Females appeared slightly more susceptible than males (1.5 OR). The approach offers the advantages of (1) improved statistical power by combining exposures, (2) insight into the dose-response relationship of altitude exposure and AMS risk, (3) quantitative tests for the significance of factors that might affect AMS susceptibility, and (4) practical tools to track individual climbers and plan operational ascents.
引用
收藏
页码:32 / 42
页数:11
相关论文
共 30 条
[1]  
BANDERET LE, 1977, AVIAT SPACE ENVIR MD, V48, P19
[2]  
Basnyat B, 1999, AVIAT SPACE ENVIR MD, V70, P867
[3]   RELATIONSHIP OF MOUNTAIN-SICKNESS TO PHYSICAL-FITNESS AND EXERCISE INTENSITY DURING ASCENT [J].
BIRCHER, HP ;
EICHENBERGER, U ;
MAGGIORINI, M ;
OELZ, O ;
BARTSCH, P .
JOURNAL OF WILDERNESS MEDICINE, 1994, 5 (03) :302-311
[4]  
EVANS WO, 1976, AVIAT SPACE ENVIR MD, V47, P512
[5]  
Fleiss J., 1986, Reliability of measurement: the design and analysis of clinical experiments
[6]  
GUPTA JS, 1978, J MED RES, V68, P312
[7]   RALES, PERIPHERAL EDEMA, RETINAL HEMORRHAGE AND ACUTE MOUNTAIN-SICKNESS [J].
HACKETT, PH ;
RENNIE, D .
AMERICAN JOURNAL OF MEDICINE, 1979, 67 (02) :214-218
[8]  
HACKETT PH, 1976, LANCET, V2, P1149
[9]   Current concepts: High-altitude illness. [J].
Hackett, PH ;
Roach, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (02) :107-114
[10]   INFLUENCE OF ELEVATION OF ORIGIN RATE OF ASCENT AND A PHYSICAL CONDITIONING PROGRAM ON SYMPTOMS OF ACUTE MOUNTAIN SICKNESS [J].
HANSEN, JE ;
HARRIS, CW ;
EVANS, WO .
MILITARY MEDICINE, 1967, 132 (08) :585-+